/

Other

/

Ultragenyx

Ultragenyx

Ultragenyx

Verified Nov 2026

Other

·

United States flag

Novato, California

·

Since 2010

Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.

Ultragenyx

Verified Nov 2026

AT A GLANCE

Founded

2010

Headquarters

United States flag

Novato, California

Employees

1,000-5,000

Ownership

Ultragenyx at a glance

Revenue

$500M-1B

Est. band

Employees

1,000-5,000

Founded

2010

Headquarters

Novato, California

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.

At a glance

Attribute

Detail

Founded

2010

Headquarters

Novato, California

Employees

1,000-5,000

Revenue

$500M-1B (estimated)

What Ultragenyx makes

The company's portfolio includes monoclonal antibodies, enzyme replacement therapies, small molecules, antisense oligonucleotides, mRNA therapies, and gene therapies targeting genetic disorders with high unmet medical needs.

Latest developments

Facilities

Ultragenyx is headquartered in Novato, California. Public sources also reference these locations:

Company details

Ultragenyx operates in 12 countries and maintains significant clinical and manufacturing infrastructure, with facilities including operations in Bedford, Massachusetts. Ultragenyx was founded in 2010, has an estimated 1,000-5,000 employees, and is headquartered in Novato, California.

Frequently asked questions

What does Ultragenyx do?

Ultragenyx is a biopharmaceutical company founded in 2010 and headquartered in Novato, California, with 1,000–5,000 employees and estimated revenue of $500 million to $1 billion. The company develops therapies for rare and ultra-rare genetic diseases across multiple modalities, including enzyme replacement therapies, gene therapies, and small molecules. It markets four approved products for conditions such as X-linked hypophosphatemia and mucopolysaccharidosis VII, and operates research and manufacturing facilities across the United States, Mexico, Colombia, Spain, and the United Kingdom.

Where is Ultragenyx headquartered?

Ultragenyx is headquartered in Novato, California (60 Leveroni Court, Novato, California, 94949).

When was Ultragenyx founded?

Ultragenyx was founded in 2010.

How big is Ultragenyx?

Ultragenyx has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Novato, California (HQ)Headquarters · United States
Novato, California (HQ)60 Leveroni Court, Novato, California, 94949, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.